This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Syensqo Specialty Polymers USA, LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Keshav S Gautam: Innovator in Bioactive Polymers
Introduction
Keshav S Gautam is a notable inventor based in Suwanee, GA (US). He has made significant contributions to the field of polymer science, particularly in the development of bioactive compounds. His innovative work has the potential to impact medical applications, especially in hemodialysis.
Latest Patents
Keshav holds a patent for a groundbreaking invention titled "Bioactive compound immobilization on sulfone polymers." This invention relates to a poly(aryl ether sulfone) (PAES) copolymer with ionically and/or covalently attached bioactive compounds. The methods described in the patent allow for the creation of articles, such as membranes, that incorporate these advanced materials. Notably, the invention enables the immobilization of antithrombotic agents like heparin, which can be used to form bioactive membrane structures suitable for hemodialysis. This innovation aims to eliminate the need for direct injection of such agents into patients undergoing treatment.
Career Highlights
Keshav is currently associated with Syensqo Specialty Polymers USA, LLC, where he continues to advance his research in specialty polymers. His work focuses on functionalized side-chain PAES copolymers, which facilitate the immobilization of bioactive compounds for various applications.
Collaborations
Keshav collaborates with talented professionals in his field, including Kamlesh Nair and Goliver DeJESUS. Their combined expertise contributes to the innovative projects at Syensqo Specialty Polymers USA, LLC.
Conclusion
Keshav S Gautam is a pioneering inventor whose work in bioactive polymers is paving the way for advancements in medical technology. His contributions are significant and hold promise for improving patient care in hemodialysis and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile